Retatrutide is a cutting-edge investigational peptide developed for research into weight management, fitness enhancement, and metabolic health. Presented as a lyophilized (freeze-dried) powder in 5mg/vial, 10mg/vial, 20mg/vial, 30mg/vial, 40mg/vial, this peptide offers high purity and long-term stability, making it ideal for storage, reconstitution, and precise dosing in laboratory or clinical development settings.
Retatrutide functions as a multi-receptor agonist, activating key hormonal pathways involved in regulating appetite, glucose metabolism, and fat utilization. Its action may contribute to reduced food intake, increased satiety, and enhanced fat-burning, showing promise in the treatment of obesity, metabolic syndrome, and related conditions. Research has demonstrated Retatrutide’s potential to significantly reduce body weight while maintaining lean muscle mass, making it a valuable subject of interest in both fitness and therapeutic studies.
This lyophilized peptide is produced under strict GMP standards, ensuring purity ≥98%, low endotoxin levels, and reliable consistency for scientific applications. It is intended strictly for research use and must be reconstituted with sterile water or buffer before injection or experimentation. Stored properly at 2–8°C, the powder remains stable for extended periods.
| Product Name | Retatrutide Peptide |
| Shelf Life | 2 Years |
| Form | Peptide |
| Indication | Weight Loss |
| Dosage | 1mg~12mg/week |
| Active Ingredient | Retatrutide |
| Storage Conditions | Store At 2-25°C |
| Packaging | 10mg/vial, 15mg/vial, 20mg/vial, 30mg/vial, 40mg/vial |
Our Retatrutide peptide is manufactured under strict Good Manufacturing Practice (GMP) conditions, ensuring purity ≥98% and minimal endotoxin levels. It is intended exclusively for laboratory, preclinical, and clinical development use. Common research applications include:
(1) Obesity and Metabolic Syndrome Models: Investigating Retatrutide’s effects on weight reduction, fat oxidation, and energy balance in rodent or primate studies.
(2) Glucose Regulation Studies: Examining improvements in glycemic control, insulin secretion dynamics, and pancreatic β‑cell function.
(3) Appetite and Feeding Behavior Research: Assessing changes in food intake patterns, satiety responses, and neuroendocrine signaling.
For high value products, please select air shipping and express delivery for safety.
